MetaStat Competitors and Similar CompaniesClear all

MetaStat's competitors and similar companies include Salarius Pharmaceuticals, Immutep, Bexion Pharmaceuticals and Bold Therapeutics.
MetaStat
MetaStat
MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.
Salarius Pharmaceuticals
Salarius Pharmaceuticals
Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
Immutep
Immutep
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
Bexion Pharmaceuticals
Bexion Pharmaceuticals
Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
Bold Therapeutics
Bold Therapeutics
Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers.
Founding Date
Founding Date
2010
Founding Date
2011
Founding Date
2001
Founding Date
2006
Founding Date
2018
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Boston, US HQ
Locations
Houston, US HQ
Locations
Sydney, AU HQ
Sydney, AU
The Rocks, AU
Orsay, FR
Berlin, DE
Leipzig, DE
Locations
Covington, US HQ
Locations
Vancouver, CA HQ
Employees
Employees
6
Employees
2
Employees
2427% decrease
Employees
274% increase
Employees
205% increase
Valuation ($)
Valuation ($)
20.6 k
Valuation ($)
2.4 m
Valuation ($)
282.4 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$23.3k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($3.2m) (FY, 2018)
Net income
N/A
Net income
($61.4m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 350k
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16.6m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Salarius Pharmaceuticals
HQ
Houston, US
Employees
2

Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.

View company
Immutep
HQ
Sydney, AU
Employees
24↓ 27% decrease

Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.

View company
Bexion Pharmaceuticals
HQ
Covington, US
Employees
27↑ 4% increase

Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.

View company
Bold Therapeutics
HQ
Vancouver, CA
Employees
20↑ 5% increase

Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers.

View company